Target intelligence / Profile preview

Ribosomal protein L6 pseudogene 3 (RPL6P3)

Target: RPL6P3
Molecular classification: Other (processed pseudogene, not part of common target families such as receptor, enzyme, transporter, etc.)

Overview

Ribosomal protein L6 pseudogene 3 (RPL6P3) is a processed pseudogene of the ribosomal protein L6 gene, found within the human genome and annotated as non-coding, meaning it does not produce a functional protein. Pseudogenes like RPL6P3 arise from the duplication or retrotransposition of functional gene sequences, usually accumulating mutations that prevent them from being expressed or translated into protein. No evidence suggests RPL6P3 is involved in disease, drug response, cell signaling, or other canonical biological roles. It is not considered a valid therapeutic target, nor is it used as a biomarker in research or clinical practice.

Other names: RPL6_2_187RPL6P3

Beyond the preview

Go deeper on Ribosomal protein L6 pseudogene 3 (RPL6P3).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ribosomal protein L6 pseudogene 3 (RPL6P3).

Explore the full profile